Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Jenner

Showing results (281-290 of 548) with videos related to

Pageof 55
Sort By:
Neuropharmacology|April 1, 1987
In vitro characterisation of dopamine receptors in the superior colliculus of the ratM E Weller, S Rose, P Jenner, et al.
British Journal of Pharmacology|March 1, 1977
Central dopaminergic and noradrenergic components of bromocryptine-induced locomotor activity in mice [proceedings]A C Dolphin, P Jenner, C D Marsden, et al.
Biochemical Pharmacology|September 1, 1983
Persistent increase in striatal dopamine stimulated adenylate cyclase activity persists for more than 6 months but disappears after 1 year following withdrawal from 18 months cis-flupenthixol intakeK Murugaiah, S Fleminger, A Theodorou, et al.
European Journal of Pharmacology|December 30, 1996
Dopamine D3 receptors are not involved in the induction of c-fos mRNA by neuroleptic drugs: comparison of the dopamine D3 receptor antagonist GR103691 with typical and atypical neurolepticsM J Hurley, C M Stubbs, P Jenner, et al.
Advances in Neurology|July 20, 1999
P450 and heme oxygenase enzymes in the basal ganglia and their roles in Parkinson's diseaseA G Riedl, P M Watts, C T Brown, et al.
Annals of the New York Academy of Sciences|June 15, 1996
Oxidative stress and Parkinson's diseaseA D Owen, A H Schapira, P Jenner, et al.
Neurodegeneration : a Journal for Neurodegenerative Disorders, Neuroprotection, and Neuroregeneration|June 1, 1996
Repeated administration of escalating high doses of dexfenfluramine does not produce morphological evidence for neurotoxicity in the cortex of ratsS Rose, S Hunt, P Collins, et al.
Neuropharmacology|May 1, 1994
An autoradiographic study of the differential effects of N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) on striatal and extrastriatal D-1 and D-2 dopamine receptors in the ratK K Gnanalingham, A J Hunter, P Jenner, et al.
The Journal of Pharmacy and Pharmacology|January 1, 1980
Stereoselective actions of substituted benzamide drugs on cerebral dopamine mechanismsP Jenner, A Clow, C Reavill, et al.
British Journal of Pharmacology|October 1, 1975
Proceedings: The role of dopamine in rotational behaviour produced by unilateral lesions of the locus coeruleusI Donaldson, A Dolphin, P Jenner, et al.
Pageof 55

Showing results (281-290 of 548) with videos related to

Sort By:
Pageof 55
Neuropharmacology|April 1, 1987
In vitro characterisation of dopamine receptors in the superior colliculus of the ratM E Weller, S Rose, P Jenner, et al.
British Journal of Pharmacology|March 1, 1977
Central dopaminergic and noradrenergic components of bromocryptine-induced locomotor activity in mice [proceedings]A C Dolphin, P Jenner, C D Marsden, et al.
Biochemical Pharmacology|September 1, 1983
Persistent increase in striatal dopamine stimulated adenylate cyclase activity persists for more than 6 months but disappears after 1 year following withdrawal from 18 months cis-flupenthixol intakeK Murugaiah, S Fleminger, A Theodorou, et al.
European Journal of Pharmacology|December 30, 1996
Dopamine D3 receptors are not involved in the induction of c-fos mRNA by neuroleptic drugs: comparison of the dopamine D3 receptor antagonist GR103691 with typical and atypical neurolepticsM J Hurley, C M Stubbs, P Jenner, et al.
Advances in Neurology|July 20, 1999
P450 and heme oxygenase enzymes in the basal ganglia and their roles in Parkinson's diseaseA G Riedl, P M Watts, C T Brown, et al.
Annals of the New York Academy of Sciences|June 15, 1996
Oxidative stress and Parkinson's diseaseA D Owen, A H Schapira, P Jenner, et al.
Neurodegeneration : a Journal for Neurodegenerative Disorders, Neuroprotection, and Neuroregeneration|June 1, 1996
Repeated administration of escalating high doses of dexfenfluramine does not produce morphological evidence for neurotoxicity in the cortex of ratsS Rose, S Hunt, P Collins, et al.
Neuropharmacology|May 1, 1994
An autoradiographic study of the differential effects of N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) on striatal and extrastriatal D-1 and D-2 dopamine receptors in the ratK K Gnanalingham, A J Hunter, P Jenner, et al.
The Journal of Pharmacy and Pharmacology|January 1, 1980
Stereoselective actions of substituted benzamide drugs on cerebral dopamine mechanismsP Jenner, A Clow, C Reavill, et al.
British Journal of Pharmacology|October 1, 1975
Proceedings: The role of dopamine in rotational behaviour produced by unilateral lesions of the locus coeruleusI Donaldson, A Dolphin, P Jenner, et al.
Pageof 55